Kovack Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History

Kovack Advisors’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,724	Closed	-$632K	–	776
2021 Q3	$632K	Buy	+3,724	New	+$580K	0.07%	319

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Kovack Advisors's SGEN Position: Q4 2021 in Review

Kovack Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q4 2021, closing a stake of 3,724 shares — an estimated $632K sold.

Kovack Advisors first reported a position in SGEN in Q3 2021 and held it in 1 quarter. The position peaked at $632K in Q3 2021. 526 funds tracked by Wall St. Rank hold SGEN as of Q4 2021.

Kovack Advisors reported no remaining Seagen Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Kovack Advisors sold 3,724 Seagen Inc. Common Stock shares in Q4 2021, an estimated $632K.
Kovack Advisors first reported a position in Seagen Inc. Common Stock in Q3 2021 and held it in 1 quarter.
Kovack Advisors's Seagen Inc. Common Stock position peaked at $632K in Q3 2021.
526 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2021.

Based on Kovack Advisors's 13F filing for Q4 2021, filed 18 Jan 2022.